U.S. patent application number 10/608978 was filed with the patent office on 2004-05-06 for method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation.
This patent application is currently assigned to Innercool Therapies, Inc.. Invention is credited to Dobak, John D. III, Kramer, Hans W., Yon, Steve A..
Application Number | 20040087934 10/608978 |
Document ID | / |
Family ID | 27489491 |
Filed Date | 2004-05-06 |
United States Patent
Application |
20040087934 |
Kind Code |
A1 |
Dobak, John D. III ; et
al. |
May 6, 2004 |
Method and device for performing cooling- or cryo-therapies for,
E.G., angioplasty with reduced restenosis or pulmonary vein cell
necrosis to inhibit atrial fibrillation
Abstract
The present invention provides an enhanced method and device to
inhibit or reduce the rate of restenosis following angioplasty or
stent placement. The invention involves placing a balloon tipped
catheter in the area treated or opened through balloon angioplasty
immediately following angioplasty. The balloon, which can have a
dual balloon structure, may be delivered through a guiding catheter
and over a guidewire already in place from a balloon angioplasty. A
fluid such as a perfluorocarbon may be flowed into the balloon to
freeze the tissue adjacent the balloon, this cooling being
associated with reduction of restenosis. The catheter may also be
used to reduce atrial fibrillation by inserting and inflating the
balloon such that an exterior surface of the balloon is in contact
with at least a partial circumference of the portion of the
pulmonary vein adjacent the left atrium.
Inventors: |
Dobak, John D. III; (La
Jolla, CA) ; Kramer, Hans W.; (Temecula, CA) ;
Yon, Steve A.; (San Diego, CA) |
Correspondence
Address: |
INNERCOOL THERAPIES
3931 Sorrento Valley Blvd.
San Diego
CA
92121
US
|
Assignee: |
Innercool Therapies, Inc.
|
Family ID: |
27489491 |
Appl. No.: |
10/608978 |
Filed: |
June 26, 2003 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10608978 |
Jun 26, 2003 |
|
|
|
09787599 |
Mar 21, 2001 |
|
|
|
6602276 |
|
|
|
|
09787599 |
Mar 21, 2001 |
|
|
|
PCT/US01/06648 |
Mar 1, 2001 |
|
|
|
09787599 |
Mar 21, 2001 |
|
|
|
09516319 |
Mar 1, 2000 |
|
|
|
09516319 |
Mar 1, 2000 |
|
|
|
09103342 |
Jun 23, 1998 |
|
|
|
6096068 |
|
|
|
|
09516319 |
Mar 1, 2000 |
|
|
|
09052545 |
Mar 31, 1998 |
|
|
|
6231595 |
|
|
|
|
09516319 |
Mar 1, 2000 |
|
|
|
09215038 |
Dec 16, 1998 |
|
|
|
6261312 |
|
|
|
|
Current U.S.
Class: |
606/21 ;
606/23 |
Current CPC
Class: |
A61B 18/02 20130101;
A61B 2017/22054 20130101; A61B 2018/0212 20130101; A61F 2007/0056
20130101; A61B 2017/22002 20130101; A61B 2018/00041 20130101; A61B
18/08 20130101; A61B 2017/22051 20130101; A61B 2018/0262 20130101;
A61F 7/12 20130101; A61F 2007/0298 20130101; A61F 7/123 20130101;
A61F 2007/0054 20130101; A61B 2018/00023 20130101; A61F 2007/126
20130101; A61B 2018/0022 20130101 |
Class at
Publication: |
606/021 ;
606/023 |
International
Class: |
A61B 018/02 |
Claims
What is claimed is:
1. A device to treat tissue, comprising: an outer tube; an inner
tube disposed at least partially within the outer tube; and a dual
balloon including an inner balloon and an outer balloon, the inner
balloon coupled to the inner tube at a proximal end and at a distal
end, the outer balloon coupled to the inner tube at a distal end
and to the outer tube at a proximal end, a first interior volume
defined between the outer balloon and the inner balloon in fluid
communication with an inlet in the volume between the outer tube
and the inner tube.
2. The device of claim 1, wherein the inner tube further defines: a
guidewire lumen; a supply lumen; and a return lumen.
3. The device of claim 2, wherein the supply lumen defines a hole
such that a fluid flowing in the supply lumen may be caused to flow
into a volume defined by the inner balloon, and wherein the return
lumen defines a hole such that a fluid flowing in a volume defined
by the inner balloon may be caused to flow into the return
lumen.
4. The device of claim 2, wherein the guidewire lumen extends from
a proximal end of the inner tube to a distal end of the inner
tube.
5. The device of claim 1, further comprising at least two radially
extending tabs disposed around a circumference of the inner tube to
substantially center the inner tube within the dual balloon.
6. The device of claim 1, further comprising at least one marker
band disposed on the inner tube to locate a working region of the
device at a desired location.
7. The device of claim 1, further comprising a source of chilled
fluid having a supply tube and a return tube, the supply tube
coupled in fluid communication to the supply lumen and the return
tube coupled in fluid communication to the return lumen.
8. The device of claim 1, further comprising a source of fluid, the
source of fluid coupled in fluid communication to the volume
between the inner balloon and the outer balloon.
9. The device of claim 7, wherein the fluid is a
perfluorocarbon.
10. The device of claim 9, wherein the fluid is Galden.RTM.
fluid.
11. The device of claim 10, wherein the fluid is Galden.RTM. fluid
HT-55.
12. The device of claim 8, wherein the fluid includes contrast
media.
13. The device of claim 8, wherein the source of fluid includes a
gear pump.
14. The device of claim 13, wherein the gear pump is one selected
from the group consisting of a radial spur gear pump and a helical
tooth gear pump.
15. A method of reducing restenosis after angioplasty in a blood
vessel, comprising: inserting a catheter into a blood vessel, the
catheter having a balloon; inflating the balloon with a
perfluorocarbon such that an exterior surface of the balloon is in
contact with at least a partial inner perimeter of the blood
vessel, the perfluorocarbon having a temperature in the range of
about -10.degree. C. to -50.degree. C.
16. The method of claim 15, further comprising the step of
disposing the catheter at a desired location using at least one
marker band.
17. The method of claim 15, further comprising flowing the
perfluorocarbon into the balloon using a supply lumen and
exhausting the perfluorocarbon from the balloon using a return
lumen.
18. The method of claim 15, wherein the balloon is a dual balloon,
and further comprising providing a heat transfer fluid in the
volume between the dual balloons.
19. The method of claim 18, wherein the heat transfer fluid
includes a contrast media fluid.
20. The method of claim 15, further comprising disposing the
catheter such that at least a portion of the balloon is in a
coronary artery.
21. The method of claim 15, further comprising disposing the
catheter such that at least a portion of the balloon is in a
carotid artery.
22. A method of reducing atrial fibrillation, comprising: inserting
a catheter at least partially into the heart, the catheter having a
balloon, a portion of the balloon located in the left atrium and a
portion of the balloon located in a pulmonary vein; inflating the
balloon with a perfluorocarbon such that an exterior surface of the
balloon is in contact with at least a partial circumference of the
portion of the pulmonary vein adjacent the left atrium, the
perfluorocarbon having a temperature in the range of about
-10.degree. C. to -50.degree. C.
23. The method of claim 22, wherein the balloon has a working
region having a length of between about 5 mm and 10 mm.
24. The method of claim 22, further comprising: inserting a wire
capable of rupturing the atrial septum from the femoral vein into
the right atrium; forming a hole using the wire in the interatrial
septum between the right atrium and the left atrium; inserting a
guide catheter into the right atrium; inserting a guide wire
through the guide catheter into the right atrium and further into a
pulmonary vein; disposing the catheter over the guidewire into a
volume defined by the joint of the right atrium and the pulmonary
vein.
25. A catheter system for vessel ablation, comprising: a catheter
shaft; a warm balloon disposed on the catheter shaft, said warm
balloon fluidically coupled to at least one lumen for inflating and
deflating the warm balloon; and a cold balloon disposed on the
catheter shaft, said cold balloon fluidically coupled to two lumens
for circulating a cold working fluid to and from the cold balloon,
such that said cold balloon is located adjacent but proximal to
said warm balloon.
26. The system of claim 25, wherein said warm balloon is made of
silicone tubing.
27. The system of claim 26, wherein said warm balloon is secured by
heat shrink tubing.
28. The system of claim 26, wherein said warm balloon is secured by
an adhesive.
29. The system of claim 26, wherein said warm balloon is secured by
bands.
30. The system of claim 29, wherein said bands are metal.
31. The system of claim 25, wherein said working fluid is a
perfluorocarbon.
32. The system of claim 31, wherein said working fluid is Galden
fluid.
33. The system of claim 25, wherein said warm balloon is structured
and configured to anchor in a pulmonary vein.
34. The system of claim 33, wherein said cold balloon is structured
and configured to be disposed partially in a pulmonary vein and
partially in the left atrium.
35. The system of claim 34, wherein said cold balloon has a length
of between about 1 to 21/2 cm and a diameter of between about 1 to
21/2 cm.
36. The system of claim 25, further comprising at least one marker
band disposed within one or both of the cold balloon and the warm
balloon.
37. The system of claim 25, further comprising a set of mapping
electrodes disposed distal of the warm balloon.
38. The system of claim 25, further comprising an insulation sleeve
disposed around the catheter shaft.
39. The system of claim 38, wherein the insulation sleeve is formed
of a foamed extrusion.
40. The system of claim 25, further comprising a silicone sleeve
disposed circumferentially about the catheter shaft adjacent a
point at which at least one of the cold or warm balloons attaches
to the catheter shaft.
41. The system of claim 25, wherein the cold balloon is doped with
a biocompatible agent to promote heat transfer.
42. A method of reducing atrial fibrillation, comprising: inserting
a catheter at least partially into the heart, the catheter having a
warm balloon and a cold balloon proximal of the warm balloon, at
least a portion of the cold balloon located in the left atrium and
at least a portion of the warm balloon located in a pulmonary vein;
inflating the warm balloon with a biocompatible fluid; and
inflating the cold balloon with a perfluorocarbon such that an
exterior surface of the cold balloon is in contact with at least a
partial circumference of the portion of the pulmonary vein adjacent
the left atrium, the perfluorocarbon having a temperature in the
range of about -10.degree. C. to -70.degree. C.
43. The method of claim 42, wherein inflating the warm balloon
includes pressurizing the warm balloon to a pressure of between
about 1 to 2 atmospheres.
44. The method of claim 42, wherein inflating the cold balloon
includes pressurizing the cold balloon to a pressure of between
about 5 to 7 atmospheres.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a divisional of U.S. patent application
Ser. No. 09/787,599, filed Mar. 21, 2001, entitled "Method And
Device For Performing Cooling-Or Cryo-Therapies For, E. G.,
Angioplasty With Reduced Restenosis Or Pulmonary Vein Cell Necrosis
To Inhibit Atrial Fibrillation" which is a 371 National Phase
Application claiming priority to PCT Serial No. PCT/US01/06648,
filed Mar. 1, 2001, entitled "Method And Device For Performing
Cooling-Or Cryo-Therapies For, E. G., Angioplasty With Reduced
Restenosis Or Pulmonary Vein Cell Necrosis To Inhibit Atrial
Fibrillation" which is a continuation-in-part of U.S. patent
application Ser. No. 09/516,319, filed Mar. 1, 2000, entitled
"Method and Device for Performing Cooling-or Cryo-Therapies for,
e.g., Angioplasty with Reduced Restenosis or Pulmonary Vein Cell
Necrosis to Inhibit Atrial Fibrillation" which is a
continuation-in-part of U.S. patent application Ser. No.
09/103,342, filed Jun. 23, 1998, entitled "Selective Organ Cooling
Catheter And Method Of Using The Same" and of U.S. patent
application Ser. No. 09/052,545, filed Mar. 31, 1998, entitled
"Circulating Fluid Hypothermia Method and Apparatus" and of U.S.
patent application Ser. No. 09/215,038, filed Dec. 16, 1998,
entitled "Inflatable Catheter for Selective Organ Heating and
Cooling and Method of Using the Same", all of which are
incorporated herein by reference.
BACKGROUND OF THE INVENTION
[0002] Balloon angioplasty, or the technology of reshaping of a
blood vessel for the purpose of establishing vessel patency using a
balloon tipped catheter, has been known since the late 1970's. The
procedure involves the use of a balloon catheter that is guided by
means of a guidewire through a guiding catheter to the target
lesion or vessel blockage. The balloon typically is equipped with
one or more marker bands that allow the interventionalist to
visualize the position of the balloon in reference to the lesion
with the aid of fluoroscopy. Once in place, i.e., centered with the
lesion, the balloon is inflated with a biocompatible fluid, and
pressurized to the appropriate pressure to allow the vessel to
open.
[0003] Typical procedures are completed with balloon inflation
pressures between 8 and 12 atmospheres. A percentage of lesions,
typically heavily calcified lesions, require much higher balloon
inflation pressures, e.g., upward of 20 atmospheres. At times, the
balloon inflation procedure is repeated several times before the
lesion or blockage will yield. The placement of stents after
angioplasty has become popular as it reduces the rate of
restenosis.
[0004] Restenosis refers to the renarrowing of the vascular lumen
following vascular intervention such as a balloon angioplasty
procedure or stent insertion. Restenosis is clinically defined as a
greater than 50% loss of initial lumen diameter. The mechanism or
root causes of restenosis are still not fully understood. The
causes are multifactorial, and are partly the result of the injury
caused by the balloon angioplasty procedure and stent placement.
With the advent of stents, restenosis rates have dropped from over
30% to 10-20%. Recently, the use and effectiveness of low-dose
radiation administered intravascularly following angioplasty is
being evaluated as a method to alter the DNA or RNA of an affected
vessel's cells in the hope of reducing cell proliferation.
[0005] Besides restenosis, another cardiological malady is atrial
fibrillation. Atrial fibrillation refers to very rapid irregular
contractions of the atria of the heart resulting in a lack of
synchronization between the heartbeat and the pulse. The irregular
contractions are due to irregular electrical activity that
originates in the area of the pulmonary veins. A proposed device,
currently under development, for treating atrial fibrillation is a
balloon filled with saline that can be ultrasonically agitated and
heated. This device is inserted in the femoral vein and snaked into
the right atrium. The device is then poked through the interatrial
septum and into the left atrium, where it is then angled into the
volume adjoining the suspect pulmonary vein with the left
atrium.
[0006] Research in atrial fibrillation indicates that substantially
complete circumferential necrosis is required for a therapeutic
benefit. The above technique is disadvantageous in that
circumferential portions of the tissue, desired to be necrosed, are
not in fact affected. Other techniques, including RF ablation, are
similarly inefficient. Moreover, these techniques leave the
necrosed portions with jagged edges, i.e., there is poor
demarcation between the healthy and the necrosed tissue. These
edges can then cause electrical short circuits, and associated
electrical irregularities, due to the high electric fields
associated with jagged edges of a conductive medium.
[0007] The above technique is also disadvantageous in that heating
is employed. Heating is associated with several problems, including
increased coagulum and thrombus formation, leading to emboli.
Heating also stimulates stenosis of the vein. Finally, since
tissues can only safely be heated to temperatures of less than or
about 75.degree. C.-85.degree. C. due to charring and tissue
rupture secondary to steam formation. The thermal gradient thus
induced is fairly minimal, leading to a limited heat transfer.
Moreover, since heating causes tissues to become less adherent to
the adjacent heat transfer element, the tissue contact with the
heat transfer element is also reduced, further decreasing the heat
transfer.
SUMMARY OF THE INVENTION
[0008] The present invention provides an enhanced method and device
to inhibit or reduce the rate of restenosis following angioplasty
or stent placement. The invention is similar to placing an ice pack
on a sore or overstrained muscle for a period of time to minimize
or inhibit the bio-chemical events responsible for an associated
inflammatory response. An embodiment of the invention generally
involves placing a balloon-tipped catheter in the area treated or
opened through balloon angioplasty immediately following
angioplasty. A so-called "cryoplasty" balloon, which can have a
dual balloon structure, may be delivered through a guiding catheter
and over a guidewire already in place from a balloon angioplasty.
The dual balloon structure has benefits described below and also
allows for a more robust design, providing significant safety
advantages to the patient because two balloons must be broken if
cooling fluid is to deleteriously infuse into the patient.
[0009] The dual balloon may be centered in the recently opened
vessel with the aid of radio opaque marker bands, indicating the
"working length" of the balloon. In choosing a working length, it
is important to note that typical lesions may have a size on the
order of 2-3 cm. A biocompatible heat transfer fluid, which may
contain contrast media, may be infused through the space between
the dual balloons. While this fluid does not circulate in this
embodiment, once it is chilled or even frozen by thermal contact
with a cooling fluid, it will stay sufficiently cold for
therapeutic purposes. Subsequently, a biocompatible cooling fluid
with a temperature between about, e.g., -40.degree. C. and
-60.degree. C., may be injected into the interior of the inner
balloon, and circulated through a supply lumen and a return lumen.
The fluid exits the supply lumen through a skive in the lumen, and
returns to the refrigeration unit via another skive and the return
lumen.
[0010] The biocompatible cooling fluid chills the biocompatible
heat transfer fluid between the dual balloons to a therapeutic
temperature between about, e.g., 0.degree. C. and -50.degree. C.
The chilled heat transfer fluid between the dual balloons transfers
thermal energy through the balloon wall and into the adjacent
intimal vascular tissue for the appropriate therapeutic length of
time. Upon completion of the therapy, the circulation of the
biocompatible cooling fluid is stopped, and the heat transfer fluid
between the dual balloons withdrawn through the annular space. Both
balloons may be collapsed by means of causing a soft vacuum in the
lumens. Once collapsed, the cryoplasty catheter may be withdrawn
from the treated site and patient through the guiding catheter.
[0011] In more detail, in one aspect, the invention is directed to
a device to treat tissue, including an outer tube, an an inner tube
disposed at least partially within the outer tube, and a dual
balloon including an inner balloon and an outer balloon, the inner
balloon coupled to the inner tube at a proximal and at a distal
end, the outer balloon coupled to the inner tube at a distal end
and to the outer tube at a proximal end. A first interior volume is
defined between the outer balloon and the inner balloon in fluid
communication with an inlet in the volume between the outer tube
and the inner tube.
[0012] Variations of the invention may include one or more of the
following. The inner tube may further define a guidewire lumen, a
supply lumen, and return lumen. The supply lumen may define a hole
or skive such that a fluid flowing in the supply lumen may be
caused to flow into a volume defined by the inner balloon, and the
return lumen may define a hole or skive such that a fluid flowing
in a volume defined by the inner balloon may be caused to flow into
the return lumen. The guidewire lumen may extend from a proximal
end of the inner tube to a distal end of the inner tube. The device
may further comprise at least two radially extending tabs disposed
around a circumference of the inner tube to substantially center
the inner tube within the dual balloon. The device may further
comprise at least one marker band disposed on the inner tube to
locate a working region of the device at a desired location. The
device may further comprise a source of chilled fluid having a
supply tube and a return tube, the supply tube coupled in fluid
communication to the supply lumen and the return tube coupled in
fluid communication to the return lumen. A source of fluid may also
be included, the source of fluid coupled in fluid communication to
a volume between the inner balloon and the outer balloon. The fluid
may be a perfluorocarbon such as Galden fluid. The fluid may also
include contrast media.
[0013] In another aspect, the invention is directed to a method of
reducing restenosis after angioplasty in a blood vessel. The method
includes inserting a catheter into a blood vessel, the catheter
having a balloon. The balloon is then inflated with a
perfluorocarbon such that an exterior surface of the balloon is in
contact with at least a partial inner perimeter of the blood
vessel, the perfluorocarbon having a temperature in the range of
about -10.degree. C. to -50.degree. C.
[0014] Variations of the method may include one or more of the
following. The method may include disposing the catheter at a
desired location using at least one radio opaque marker band. The
method may include flowing the perfluorocarbon into the balloon
using a supply lumen and exhausting the perfluorocarbon from the
balloon using a return lumen. The balloon may be a dual balloon,
and the method may further include providing a heat transfer fluid
in the volume between the dual balloons. The heat transfer fluid
may include a contrast media fluid. The method may include
disposing the catheter such that at least a portion of the balloon
is in a coronary artery or in a carotid artery.
[0015] In yet another aspect, the invention is directed to a method
of reducing atrial fibrillation. The method includes inserting a
catheter at least partially into the heart, the catheter having a
balloon, a portion of the balloon located in the left atrium and a
portion of the balloon located in a pulmonary vein. The balloon is
then inflated with a perfluorocarbon such that an exterior surface
of the balloon is in contact with at least a partial circumference
of the portion of the pulmonary vein adjacent the left atrium, the
perfluorocarbon having a temperature in the range of about
-10.degree. C. to -50.degree. C.
[0016] Variations of the method may include one or more of the
following. The balloon may have a working region having a length of
between about 5 mm and 10 mm. The method may further include
inserting a wire having a needle point from the femoral vein into
the right atrium and forming a hole using the needle point in the
interatrial septum between the right atrium and the left atrium. A
guide catheter may then be inserted into the right atrium. A guide
wire may further be inserted through the guide catheter into the
right atrium and further into a pulmonary vein. The catheter may
then be disposed over the guidewire into a volume defined by the
joint of the right atrium and the pulmonary vein.
[0017] Advantages of the invention may include one or more of the
following. The invention inhibits or reduces the rate of restenosis
following a balloon angioplasty or any other type of vascular
intervention. At least the following portions of the vascular
anatomy can benefit from such a procedure: the abdominal aorta
(following a stent or graft placement), the coronary arteries
(following PTCA or rotational artherectomy), the carotid arteries
(following an angioplasty or stent placement), as well as the
larger peripheral arteries.
[0018] When the invention is used to treat atrial fibrillation, the
following advantages inure. The cooled tissue is adherent to the
heat transfer element, increasing the heat transfer effected. Since
very cold temperatures may be employed, the temperature gradient
can be quite large, increasing the heat transfer rate.
[0019] In both embodiments, heat transfer does not occur primarily
or at all by vaporization of a liquid, thus eliminating a potential
cause of bubbles in the body. Nor does cooling occur primarily or
at all by a pressure change across a restriction or orifice, this
simplifying the structure of the device. Thrombus formation and
charring, associated with prior techniques, are minimized or
eliminated.
[0020] Additional advantages will be apparent from the description
that follows, including the drawings and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
[0021] FIG. 1A shows a side schematic view of a catheter according
to a first embodiment of the invention.
[0022] FIG. 1B shows a cross-sectional view of the catheter of FIG.
1A, as indicated by lines 1B-1B in FIG. 1A.
[0023] FIG. 1C shows an alternate cross-sectional view of the
catheter of FIG. 1A, as indicated by lines 1B-1B in FIG. 1A.
[0024] FIG. 2A shows a side schematic view of a catheter according
to a second embodiment of the invention.
[0025] FIG. 2B shows a cross-sectional view of the catheter of FIG.
2A, as indicated by lines 2B-2B in FIG. 2A.
[0026] FIG. 3 shows a schematic view of a catheter in use according
to a third embodiment of the invention.
[0027] FIG. 4 shows a cross-sectional view of the catheter of FIG.
3.
[0028] FIG. 5 shows an alternative cross-sectional view of the
catheter of FIG. 3.
[0029] FIG. 6 shows an alternative cross-sectional view of the
catheter of FIG. 3.
[0030] FIG. 7 shows a schematic view of the warm balloon of the
catheter of FIG. 3.
DETAILED DESCRIPTION
[0031] Referring to FIG. 1A, a catheter 100 is shown according to a
first embodiment of the invention. The catheter 100 has a proximal
end 130 and a distal end 114. Of course, this figure is not
necessarily to scale and in general use the proximal end 130 is far
upstream of the features shown in FIG. 1A.
[0032] The catheter 100 may be used within a guide catheter 102,
and generally includes an outer tube 103, a dual balloon 134, and
an inner tube 122. These parts will be discussed in turn.
[0033] The guide catheter 102 provides a tool to dispose the
catheter 100 adjacent the desired location for, e.g., angioplasty
or reduction of atrial fibrillation. Typical guide catheter
diameters may be about 6 french to 9 french, and the same may be
made of polyether blockamide, polyamides, polyurethanes, and other
similar materials. The distal end of the guide catheter is
generally adjacent the proximal end of the dual balloon 134, and
further is generally adjacent the distal end of the outer tube
103.
[0034] The ability to place the guide catheter is a significant
factor in the size of the device. For example, to perform
angioplasty in the carotid arteries, which have an inner diameter
of about 4 to 6 mm, a suitably sized guide catheter must be used.
This restricts the size of the catheter 100 that may be disposed
within the guide catheter. A typical diameter of the catheter 100
may then be about 7 french or less or about 65 to 91 mils. In a
second embodiment described below, a catheter for use in the
coronary arteries is described. Of course, which catheter is used
in which artery is a matter to be determined by the physician,
taking into account such factors as the size of the individual
patient's affected arteries, etc.
[0035] The outer tube 103 houses the catheter 100 while the latter
traverses the length of the guide catheter 102. The outer tube 103
may have a diameter of about 4 french to 7 french, and the same may
be made of polyether blockamide, poly-butylene terephtalate,
polyurethane, polyamide, polyacetal polysulfone, polyethylene,
ethylene tetrafluoroethylene, and other similar materials.
[0036] The distal end of the outer tube 103 adjoins the proximal
end of the dual balloon 134. The outer tube 103 provides a
convenient location for mounting a proximal end of an outer balloon
104 within the dual balloon 134, and further may provide an inlet
128 for providing a fluid such as a liquid to a first interior
volume 106 between the dual balloons. In some cases, an inlet 128
per se may not be necessary: the fluid, which may also be a
sub-atmospheric level of gas or air, may be provided during
manufacture in the first interior volume 106. In this case, the
proximal and distal ends of the first interior volume may be sealed
during manufacture. The inlet 128 may be at least partially defined
by the annular volume between the interior of the outer tube 103
and the exterior of the inner tube 122.
[0037] The dual balloon 134 includes an outer balloon 104 and an
inner balloon 108. Between the two is the first interior volume
106. The outer balloon 104 may be inflated by inflating the
interior volume 106. The inner balloon 108 has a second interior
volume 110 associated with the same. The inner balloon 108 may be
inflated by inflating the second interior volume 110.
[0038] To avoid the occurrence of bubbles in the bloodstream, both
the inner balloon 108 and the outer balloon 104 may be inflated
using biocompatible liquids, such as Galden.RTM. fluid,
perfluorocarbon-based liquids, or various contrast agents. There is
no need that the fluid inflating one of the interior volumes be the
same fluid as that inflating the other. Additional details on these
fluids are described below.
[0039] In the case of the first interior volume 106, this fluid may
be, e.g., stationary or static: in other words, it need not be
circulated. In the case of the second interior volume 110, this
fluid would in general be circulated by an external chiller (not
shown). The chiller may be, e.g., a gear pump, peristaltic pump,
etc. It may be preferable to use a gear pump over a peristaltic
pump as the attainable pressure of the former is generally greater
than that of the latter. Moreover, gear pumps have the advantageous
property of being linear, i.e., their output varies in direction
proportion with their revolutions per minute. Two types of gear
pumps which may be employed include radial spur gear pumps and
helical tooth gear pumps. Of these, the helical tooth gear pump may
be more preferable as the same has been associated with higher
pressures and a more constant output. The ability to achieve high
pressures may be important as the cooling fluid is required to pass
through a fairly narrow, e.g., five to seven french, catheter at a
certain rate. For the same reason, the viscosity of the fluid, at
the low temperatures, should be appropriately low. In this way,
e.g., the flow may be increased. For example, an appropriate type
of fluid may be Galden.RTM. fluid, and in particular Galden.RTM.
fluid item number "HT-55", available from Ausimont Inc. of
Thorofare, N.J. At -55.degree. C., this fluid has a viscosity of
2.1 centiStokes. At -70.degree. C., this fluid has a viscosity of
3.8 centiStokes. It is believed that fluids with such viscosities
at these temperatures would be appropriate for use.
[0040] The so-called "cones" of the balloons 108 and 104, indicated
generally by reference numeral 132, may be made somewhat thicker
than the remainder of the balloon sections. In this way, the heat
transfer efficiency in these sections is significantly less than
over the remainder of the balloon sections, this "remainder"
effectively defining a "working region" of the balloon. In this
way, the cooling or "cryoplasty" may be efficiently localized to
the affected area rather than spread over the length of the
balloon.
[0041] The inner tube 122 is disposed within the interior of the
dual balloon 134 and within the interior of the guide catheter 102.
The inner tube 122 includes a supply lumen 120, a return lumen 118,
and a guidewire lumen 116. The guidewire lumen 116 may have sizes
of, e.g., 17 or 21 mils inner diameter, in order to accommodate
current standard sized guidewires, such as those having an outer
diameter of 14 mils. This structure may be preferable, as the
pressure drop encountered may be substantially less. In use, the
supply lumen 120 may be used to supply a circulating liquid to the
second interior volume 110. The return lumen 118 may be used to
exhaust the circulating liquid from the second interior volume to
the external chiller. As may be seen from FIG. 1A, both lumens 118
and 120 may terminate prior to the distal end 114 of the catheter
100. The lumen arrangement may be seen more clearly in FIG. 1B.
FIG. 1C shows an alternate such arrangement, and one that may
provide an even better design for minimal pressure drop. In this
design, lumens 118' and 120' are asymmetric about guidewire lumen
116'.
[0042] A set of radio opaque marker bands 112 may be disposed on
the inner tube 122 at locations substantially adjacent the cones
132 to define a central portion of the "working region" of the
balloons 104 and 108. This working region is where the "cryoplasty"
procedures described below may substantially occur.
[0043] As noted above, the proximal portion of the outer balloon
104 is mounted on the outer tube 103 at its distal end. The distal
end of the outer balloon 104 is secured to the distal end of the
catheter 100 and along the inner tube 122. In contrast, both the
proximal and distal ends of the inner balloon 108 may be secured to
the inner tube 122 to create a sealed second interior volume
110.
[0044] At least two skives 124 and 126 may be defined by the inner
tube 122 and employed to allow the working fluid to exit into the
second interior volume 110 and to exhaust the same from the second
interior volume 10. As shown in the figure, the skive 124 is in
fluid communication with the lumen 120 and the skive 126 is in
fluid communication with the lumen 118. Here, "fluid communication"
refers to a relationship between two vessels where a fluid pressure
may cause a net amount of fluid to flow from one vessel to the
other.
[0045] The skives may be formed by known techniques. A suitable
size for the skives may be from about 50 mils to 125 mils.
[0046] A plurality of tabs 119 may be employed to roughly or
substantially center the inner tube 122 within the catheter 100.
These tabs may have the shape shown, the shape of rectangular or
triangular solids, or other such shapes so long as the flow of
working fluid is not unduly impeded. In this specification, the
phrase "the flow of working fluid is not unduly impeded" is
essentially equated to the phrase "substantially center". The tabs
119 may be made of polyether blockamide, poly-butylene
terephtalate, polyurethane, polyamide, polyacetal polysulfone,
polyethylene, ethylene tetrafluoroethylene, and other similar
materials, and may have general dimensions of from about 3 mils to
10 mils in height, and by about 10 mils to 20 mils in width.
[0047] In a method of use, the guide catheter 102 may be inserted
into an affected artery or vein such that the distal tip of the
guide catheter is just proximal to an affected area such as a
calcified area or lesion. Of course, it is noted that typical
lesions do not occur in the venous system, but only in the
arterial.
[0048] This step provides a coarse estimate of proper positioning,
and may include the use of fluoroscopy. The guide catheter may be
placed using a guide wire (not shown). Both the guide catheter and
guide wire may already be in place as it may be presumed a balloon
angioplasty or stent placement has previously been performed.
[0049] The catheter 100 may then be inserted over the guide wire
via the lumen 116 and through the guide catheter 102. In general,
both a guide wire and a guide catheter are not strictly
necessary--one or the other may often suffice. During insertion,
the dual balloon 134 may be uninflated to maintain a minimum
profile. In fact, a slight vacuum may be drawn to further decrease
the size of the dual balloon 134 so long as the structural
integrity of the dual balloon 134 is not thereby compromised.
[0050] When the catheter 100 is distal of the distal tip of the
guide catheter 102, a fine positioning step may occur by way of the
radio opaque marker bands 112. Using fluoroscopy, the location of
the radio opaque marker bands 112 can be identified in relation to
the location of the lesion. In particular, the catheter may be
advantageously placed at the location of the lesion and further
such that the lesion is between the two marker bands. In this way,
the working region of the balloon 134 will substantially overlap
the affected area, i.e., the area of the lesion.
[0051] Once placed, a biocompatible heat transfer fluid, which may
also contain contrast media, may be infused into the first interior
volume 106 through the inlet 128. While the use of contrast media
is not required, its use may allow early detection of a break in
the balloon 104 because the contrast media may be seen via
fluoroscopy to flow throughout the patient's vasculature.
Subsequently a biocompatible cooling fluid may be circulated
through the supply lumen 120 and the return lumen 118. Before or
during the procedure, the temperature of the biocompatible cooling
fluid may be lowered to a therapeutic temperature, e.g., between
-40.degree. C. and -60.degree. C., although the exact temperature
required depends on the nature of the affected area. The fluid
exits the supply lumen 120 through the skive 124 and returns to the
chiller through the skive 126 and via the return lumen 118. It is
understood that the respective skive functions may also be reversed
without departing from the scope of the invention.
[0052] The biocompatible cooling fluid in the second interior
volume 110 chills the biocompatible heat transfer fluid within the
first interior volume 106 to a therapeutic temperature of, e.g.,
between about -25.degree. C. and -50.degree. C. The chilled heat
transfer fluid transfers thermal energy through the wall of the
balloon 104 and into the adjacent intimal vascular tissue for an
appropriate therapeutic length of time. This time may be, e.g.,
about 1/2 to 4 minutes.
[0053] Upon completion of the therapy, the circulation of the
biocompatible cooling fluid may cease. The heat transfer fluid
within the first interior volume 106 may be withdrawn though the
inlet 128. The balloons 104 and 108 may be collapsed by pulling a
soft vacuum through any or all of the lumens 124, 126, and 128.
Following collapse, the catheter 100 may be withdrawn from the
treatment site and from the patient through the guide catheter
102.
[0054] To inhibit restenosis, the following therapeutic guidelines
may be suggested:
1 Minimum Average Maximum Temperature -20.degree. C. -55.degree. C.
-110.degree. C. of heat transfer fluid Temperature 0.degree. C. to
-20.degree. C. to -50.degree. C. to achieved at -10.degree. C.
-30.degree. C. -100.degree. C. intimal wall Depth of 10ths of mm 1
mm 3 mm penetration of intema/media Length of 30 seconds 1-2 min
4-5 min time fluid is circulating
[0055] Substantially the same catheter may be used to treat atrial
fibrillation. In this method, the catheter is inflated as above
once it is in location. The location chosen for treatment of atrial
fibrillation is such that the working region spans a portion of the
left atrium and a portion of the affected pulmonary vein. Thus, in
this embodiment, the working region of the catheter may have a
length of about 5 mm to 30 mm. The affected pulmonary vein, of the
four possible pulmonary veins, which enter the left atrium, may be
determined by electrophysiology studies.
[0056] To maneuver the catheter into this location, a catheter with
a needle point may first be inserted at the femoral vein and routed
up to the right atrium. The needle of the catheter may then be
poked through the interatrial septum and into the left atrium. The
catheter may then be removed if desired and a guide catheter
disposed in the same location. A guide wire may be used through the
guide catheter and may be maneuvered at least partially into the
pulmonary vein. Finally, a catheter such as the catheter 100 may be
placed in the volume defining the intersection of the pulmonary
vein and the left atrium.
[0057] A method of use similar to that disclosed above is then
employed to cool at least a portion of, and preferably all of, the
circumferential tissue. The coldness of the balloon assists in the
adherence of the circumferential tissue to the balloon, this
feature serving to increase the overall heat transfer rate.
[0058] The catheter 100 above may be particularly useful for
procedures in the carotid arteries by virtue of its size. For use
in the coronary arteries, which are typically much smaller than the
carotid artery, an even smaller catheter may be desired. For
example, one with an outer diameter less than 5 french may be
desired.
[0059] Referring to FIG. 2A, a catheter 200 is shown according to a
second embodiment of the invention. This embodiment may be
particularly useful for use in the coronary arteries because the
dimensions of the catheter 200 may be considerably smaller than the
dimensions of the catheter 100. However, in several ways the
catheter 200 is similar to the above-described catheter 100. In
particular, the catheter 200 has a proximal end 230 and a distal
end 214 and may be used within a guide catheter 202. The catheter
200 includes an outer tube 203, a dual balloon 234, and an inner
tube 222.
[0060] The ability to place the guide catheter is a significant
factor in the size of the device. For example, to perform
angioplasty in the coronary arteries, which have an inner diameter
of about 11/2 to 41/2 mm, a suitably sized guide catheter may be
used. This then restricts the size of the catheter 200 which may be
disposed within the guide catheter. A typical diameter of the
catheter 200 may then be about 3 french or less or about 35-39
mils. The same may be placed in the femoral artery in order to be
able to track to the coronary arteries in a known manner.
[0061] Analogous to these features in the catheter 100, the outer
tube 203 houses the catheter 200 and may have an outside diameter
of about 5 french to 7 french, and the same may be made of similar
materials. The distal end of the outer tube 203 adjoins the
proximal end of the dual balloon 234. The outer tube 203 provides a
mounting location for an outer balloon 204, and further provides an
inlet 228 for providing a fluid such as a liquid to a first
interior volume 206 between the dual balloons. As noted in
connection with catheter 100, an inlet 228 per se may not be
necessary: the fluid, which may also be a sub-atmospheric level of
air, may be provided in the first interior volume 206. Also as
above, the proximal and distal ends of the volume may be sealed
during manufacture. The inlet 228 may be at least partially defined
by the annular volume between the interior of the outer tube 203
and the exterior of the inner tube 222.
[0062] The dual balloon 234 includes an outer balloon 204 and an
inner balloon 208. These balloons are basically similar to balloons
104 and 108 described above, but may be made even smaller for use
in the smaller coronary arteries.
[0063] The same types of fluids may be used as in the catheter
100.
[0064] The inner tube 222 is disposed within the interior of the
dual balloon 234 and within the interior of the guide catheter 202.
The inner tube 222 includes a supply lumen 220 and a return lumen
218.
[0065] A set of radio opaque marker bands 212 may be disposed on
the inner tube 222 for the same reasons disclosed above in
connection with the marker bands 112.
[0066] As noted above, the proximal portion of the outer balloon
204 is mounted on the outer tube 203 at its distal end. The distal
end of the outer balloon 204 is secured to the distal end of the
catheter 200 and along the inner tube 222. In contrast, both the
proximal and distal ends of the inner balloon 208 may be secured to
the inner tube 222 to create a sealed second interior volume
210.
[0067] At least two skives 224 and 226 may be defined by the inner
tube 222 and employed to allow the working fluid to exit into the
second interior volume 210 and to exhaust the same from the second
interior volume 210.
[0068] A plurality of tabs 219 may be employed to roughly or
substantially center the inner tube 222 within the catheter 200 as
in catheter 100. These tabs may have the same general geometry and
design as tabs 119. Of course, they may also be appropriately
smaller to accommodate the smaller dimensions of this coronary
artery design.
[0069] The tabs 119 and 219 are particularly important in the
catheters 100 and 200, as contact by the inner tube of the outer
tube may also be associated with an undesired conductive heat
transfer prior to the working fluid reaching the working region,
thereby deleteriously increasing the temperature of the working
fluid at the working region.
[0070] The method of use of the catheter 200 is generally the same
as for the catheter 100. Known techniques may be employed to place
the catheter 200 into an affected coronary artery. For the catheter
200, an external guidewire may be used with appropriate attachments
to the catheter.
[0071] Referring to FIG. 3, an alternative embodiment of a catheter
300 which may be employed in PV ablation is detailed. In this
figure, a dual balloon system 301 is shown; however, the balloons
are not one within the other as in FIG. 1. In this embodiment, a
warm balloon 302 is distal of a cold balloon 304. Warm balloon 302
may be used to anchor the system 301 against movements, which may
be particularly useful within a beating heart. Cold balloon 304 may
then be employed to cryo-ablate a circumferential lesion at the
point where a pulmonary vein 306 enters the left atrium 308.
[0072] Within the cold balloon 304, a working fluid may be
introduced via an outlet port 308 and may be retrieved via an inlet
port 310. Ports 308 and 310 may be skived in known fashion into the
catheter shaft lumens whose design is exemplified below.
[0073] As noted above, the warm balloon 302 serves to anchor the
system 301 in the pulmonary vein and left atrium. The warm balloon
302 also serves to stop blood, which is traveling in the direction
indicated by arrow 312, from freezing upon contact with the cold
balloon 304. In this way, the warm balloon 302 acts as an insulator
to cold balloon 304.
[0074] As the warm balloon 302 does not require convective heat
transfer via a circulating working fluid, it may be served by only
one skived port, or by two ports, such as an inlet port 314 and an
outlet port 316, as shown in FIG. 3. In some embodiments, a
separate lumen or lumens may be used to fill the warm balloon. In
an alternative embodiment, a valve mechanism may be used to fill
the warm balloon using fluid from the cold balloon. In the case
where only one port is used to fill the warm balloon, draining the
same requires a slight vacuum or negative pressure to be placed on
the lumen servicing the inlet/outlet port. A benefit to the two
lumen design is that the warm balloon may be inflated and deflated
in a more expeditious manner.
[0075] Typical pressures within the warm balloon may be about 1-2
atm (10-30 psi), and thus maintains a fairly low pressure. An
appropriate fluid will be biocompatible, and may be Galden fluid,
D5W, and so on. Typical pressures within the cold balloon may be
about 5-7 atm, for example about 6 atm (e.g., at about 100 psi),
and thus maintains a higher pressure. An appropriate fluid may be
Galden fluid, e.g., HT-55, D5W, and so on. The volume of fluid
required to fill the cold balloon may vary, but may be about 4-8
cc. The cold balloon may be about 2 to 21/2 cm long, and have a
diameter of 1 to 21/2 cm.
[0076] In some embodiments, the warm balloon may be glued or
otherwise attached to the cold balloon. In the case where only one
port is used to fill the warm balloon, draining both balloons may
simply entail closing either the return lumen or the supply lumen,
and drawing a vacuum on the other. In this way, both the cold and
warm balloons may be evacuated. In any case, a standard medical
"indeflator" may be used to pressurize and de-pressurize the
various lumens and balloons.
[0077] FIG. 4 shows an embodiment of the arrangement of lumens
within the catheter. In particular, supply and return lumens for
the cold balloon 304 are shown by lumens 318 and 320, respectively.
Supply and return lumens for the warm balloon 302 are shown by
lumens 322 and 324, respectively, although as noted only one may be
used as required by the dictates of the user. A guidewire lumen 326
is also shown. An alternative arrangement is shown in FIG. 5, where
the corresponding lumens are shown by primes.
[0078] In the above lumen designs, the exterior blood is exposed to
the cold supply flow. Referring to FIG. 6, an alternative lumen
design is shown in which the cold fluid supply lumen 328 is exposed
to only the cold fluid return lumen 330. An insulation space 332
may also be employed. In this way, the heat flux from the exterior
flow is minimized and the cold fluid may reach the cold balloon at
a lower temperature. One drawback to such a system is that the
operational pressure may be higher.
[0079] Referring back to FIG. 4, the overall catheter outer
diameter may be about 0.130", e.g. about 10 french, including an
insulation sleeve and guide discussed below. The catheter shaft 303
itself may be about 0.110" and may be made of, e.g., polyethylene
(PE), and preferably a combination of a low density PE and a high
density PE.
[0080] The inlet and outlet ports or inlet/outlet port of the warm
balloon may be skived from the lumens 322 and 324. Referring to
FIG. 7, the warm balloon 302 itself may be made of a sleeve 332 of
silicone tubing of, e.g., 35 durometer on the "D" scale, and held
in place by two pieces of PET heat shrink tubing 334. Alternative
methods of securing the warm balloon during inflation may include
metal bands or an adhesive.
[0081] Referring back to FIG. 3, marker bands 336 may be employed
within either or both of the cold balloon and warm balloon to
assist the physician is disposing the same in an appropriate
location. The marker bands typically denote the working areas of
the balloons, and may be made of Pt, Iridium, Au, etc.
[0082] In the ablation procedure, the working cold fluid may exit
the circulation system or chiller at, e.g., about -85.degree. C.
The circulation system or chiller may be, e.g., a two-stage heat
exchanger. The fluid may then enter the catheter at about
-70.degree. C. to about -75.degree. C., and may strike the balloon
at about -55.degree. C. to about -65.degree. C. The overall
procedure may take less than a minute to circumferentially ablate
the desired tissue up to several minutes. Of course, these numbers
are only exemplary and the same depend on the design of the system
and fluids used.
[0083] Mapping electrodes 338 may be employed at the distal end of
the warm balloon. These mapping electrodes may each have a wire
attached, the wires extending down, e.g., the supply and return
lumens for the warm fluid or the cold fluid. The mapping electrodes
338 may be used to detect stray electrical fields to determine
where ablation may be needed and/or whether the ablation procedure
was successful. The mapping electrodes may typically be about 2-3
mm apart from each other.
[0084] Construction of the warm balloon typically involves adhering
the same to the shaft 303 and skiving the inlet and outlet ports.
In some instances, it may be desired to place a silicone sleeve 340
on the proximal and/or distal ends of the warm and/or cold
balloons. The silicone sleeve 340 may then serve to further
insulate the non-working sections of the balloons from blood that
would otherwise potentially freeze during a procedure. The silicone
sleeve would typically be attached only at a portion of its length,
such as that indicated by circle 342, so that the same may slide
along the balloon as the balloon is inflated. In addition to
insulation effects, the silicone sleeve also serves to assist in
collapsing the balloon during deflation.
[0085] The entire catheter shaft 303 may be surrounded by an
insulation catheter sleeve 344 (see FIG. 4). Sleeve 344 may have a
thickness of, e.g., 0.01 inches, and may be made of a foamed
extrusion, e.g., that with voids of air disposed within. The voids
further assist the insulating effect since their heat transfer is
extremely low. A void to polymer ratio of, e.g., 20% to 30% may be
particularly appropriate. Such foamed extrusions are available
from, e.g., Applied Medical Resources in Laguna Niguel, Calif., or
Extrusioneering, Inc., in Temecula, Calif.
[0086] To prevent damage to tissue other than where the ablation is
to occur, such as at the insertion site near the femoral vein and
around the puncture point through the atrial septum, an insulation
sleeve may be used as noted above.
[0087] The invention has been described above with respect to
particular embodiments. It will be clear to one of skill in the art
that numerous variations may be made from the above embodiments
with departing from the spirit and scope of the invention. For
example, the invention may be combined with stent therapies or
other such procedures. The dual balloon disclosed may be used after
angioplasty or may be an angioplasty balloon itself. Furthermore,
while the invention has occasionally been termed herein a
"cryoplasty catheter", such a term is for identification purposes
only and should not be viewed as limiting of the invention. Fluids
that may be used as heat transfer fluids include
perfluorocarbon-based liquids, i.e., halogenated hydrocarbons with
an ether bond, such as FC 72. Other materials that may be used
include CFCs, Freon.RTM., or chemicals that when placed together
cause an endothermic reaction. Preferably, low viscosity materials
are used as these result generally in a lessened pressure drop. The
balloons may be made, e.g., of Pebax, PET/PEN, PE, PA 11/12, PU, or
other such materials. Either or both of the dual balloons may be
doped to improve their thermal conductivities. The shaft of inner
tube 122 may be made of Pebax, PBT, PI/PEI, PU, PA 11/12, SI, or
other such materials. The precise shapes and dimensions of the
inner and outer lumens, while indicated in, e.g., FIGS. 1B, 1C, and
2B, may vary. The lumen design shown in FIGS. 1B-1C may be employed
in the catheter of FIG. 2A and vice-versa. Embodiments of the
invention may be employed in the field of cold mapping, where a
circle of tissue is cooled to see if the affected part has been
reached. If the affected tissue is that which is being cooled, a
more vigorous cooling may be instituted. Other variations will be
clear to one of skill in the art, thus the invention is limited
only by the claims appended hereto.
* * * * *